The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $846,542 in first-year total cost, median $226,504.
Most frequent study sections
- Radiation Therapeutics and Biology Study Section[RTB]3
Most frequent institutions
- DANA-FARBER CANCER INST1
- DUKE UNIVERSITY1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Exploring synthetic lethality with a novel very high energy electron FLASH radiation beam1R21CA286097-01A1 | FLOYD, SCOTT ROLDHAM, MARKWU, YING | DUKE UNIVERSITY, NC | $413,971 | RTB |
| 2024 | Synthetic combination therapy for diffuse midline gliomas1R21CA289565-01 | VISWANATH, PAVITHRA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $226,504 | RTB |
| 2024 | Investigating Interactions Between Radiation and Antibody-Drug Conjugates in Bladder Cancer1R21CA288234-01 | MOUW, KENT W | DANA-FARBER CANCER INST, MA | $206,067 | RTB |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.